1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Dynamic methylation and expression of alternative promoters for oestrogen receptor alpha in cell line models of fulvestrant resistance
2024) In Molecular Oncology(
- Contribution to journal › Article
- 2021
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
(
- Contribution to journal › Article
-
Mark
Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer
(
- Contribution to journal › Article
-
Mark
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.
(
- Contribution to journal › Article
-
Mark
Models of breast morphogenesis based on localization of stem cells in the developing mammary lobule
(
- Contribution to journal › Article
- 2014
-
Mark
Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells
(
- Contribution to journal › Article
-
Mark
Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium
(
- Contribution to journal › Article
- 2013
-
Mark
A novel model of dormancy for bone metastatic breast cancer cells
(
- Contribution to journal › Article